(2023) Alzheimer’s disease facts and figures. Alzheimer’s & dementia: the journal of the Alzheimer’s Association 2023, 19(4):1598–1695
Breijyeh Z, Karaman R (2020) Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules 25(24)
Bourgeron T (2015) From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci 16(9):551–563
Article PubMed CAS Google Scholar
Chacón PJ, del Marco Á, Arévalo Á, Domínguez-Giménez P, García-Segura LM, Rodríguez-Tébar A (2015) Cerebellin 4, a synaptic protein, enhances inhibitory activity and resistance of neurons to amyloid-β toxicity. Neurobiol Aging 36(2):1057–1071
Citron M (2010) Alzheimer’s disease: strategies for disease modification. Nat Rev Drug Discovery 9(5):387–398
Article PubMed CAS Google Scholar
Deng Y, Zhu H, Xiao L, Liu C, Liu YL, Gao W (2021) Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer’s disease. Aging 13(21):24086–24100
Article PubMed PubMed Central CAS Google Scholar
Gerakis Y, Hetz C (2018) Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer’s disease. FEBS J 285(6):995–1011
Article PubMed CAS Google Scholar
Hampel H, Hu Y, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M et al (2023) The amyloid-β pathway in Alzheimer’s disease: a plain language summary. Neurodegenerative Disease Manage 13(3):141–149
He PC, He C (2021) M(6) a RNA methylation: from mechanisms to therapeutic potential. EMBO J 40(3):e105977
Article PubMed PubMed Central CAS Google Scholar
Hugon J, Mouton-Liger F, Dumurgier J, Paquet C (2017) PKR involvement in Alzheimer’s disease. Alzheimers Res Ther 9(1):83
Article PubMed PubMed Central Google Scholar
Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17(6):157–165
Article PubMed CAS Google Scholar
Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, Jia G, Yu M, Lu Z, Deng X et al (2014) A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol 10(2):93–95
Article PubMed CAS Google Scholar
Liu X, Wang Y (2023) Elucidating the molecular targets and mechanisms of Chlorogenic Acid against Alzheimer’s Disease via Network Pharmacology and Molecular Docking. Lett Drug Des Discovery 20(9):1329–1342
Lv Z, Xu T, Li R, Zheng D, Li Y, Li W, Yang Y, Hao Y (2022) Downregulation of m6A methyltransferase in the Hippocampus of Tyrobp (-/-) mice and implications for learning and memory deficits. Front NeuroSci 16:739201
Murakami S, Jaffrey SR (2022) Hidden codes in mRNA: control of gene expression by m(6)a. Mol Cell 82(12):2236–2251
Article PubMed PubMed Central CAS Google Scholar
Meyer KD, Jaffrey SR (2014) The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol 15(5):313–326
Article PubMed PubMed Central CAS Google Scholar
Meng S, Wang B, Li W (2022) CircAXL Knockdown alleviates Aβ(1–42)-Induced neurotoxicity in Alzheimer’s Disease via repressing PDE4A by releasing miR-1306-5p. Neurochem Res 47(6):1707–1720
Article PubMed PubMed Central CAS Google Scholar
Salaikumaran Raj M, Prasad Burra Laxmi Siva V (2023) <i > in silico design of novel SAM analogs as potential inhibitors against N2G966 16s rRNA methyltransferase (RsmD)</i >. Lett Drug Des Discovery 20(12):1898–1910
Sanfilippo C, Musumeci G, Kazakova M, Mazzone V, Castrogiovanni P, Imbesi R, Di Rosa M (2021) GNG13 is a potential marker of the state of Health of Alzheimer’s Disease patients’ Cerebellum. J Mol Neuroscience: MN 71(5):1046–1060
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer’s disease. Lancet (London England) 397(10284):1577–1590
Article PubMed CAS Google Scholar
Sehar U, Rawat P, Reddy AP, Kopel J, Reddy PH (2022) Amyloid Beta in Aging and Alzheimer’s Disease. Int J Mol Sci 23(21)
Seigneur E, Südhof TC (2017) Cerebellins are differentially expressed in selective subsets of neurons throughout the brain. J Comp Neurol 525(15):3286–3311
Article PubMed PubMed Central CAS Google Scholar
Śledź P, Jinek M (2016) Structural insights into the molecular mechanism of the m(6)a writer complex. eLife 5
Shafik AM, Zhang F, Guo Z, Dai Q, Pajdzik K, Li Y, Kang Y, Yao B, Wu H, He C et al (2021) N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer’s disease. Genome Biol 22(1):17
Article PubMed PubMed Central CAS Google Scholar
Tang Z, Cao J, Yao J, Fan X, Zhao J, Zhao M, Duan Q, Han B, Duan S (2023) KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer’s disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1. Free Radic Biol Med 195:343–358
Article PubMed CAS Google Scholar
Wang H, Jiang T, Li W, Gao N, Zhang T (2018) Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer’s disease. Toxicol Lett 282:100–108
Article PubMed CAS Google Scholar
Wang J, Zheng B, Yang S, Wang F, Wang Z, Wang J (2021) The protective effects of agomelatine against Aβ1–42 oligomers-induced cellular senescence mediated by SIRT6 and Agomelatine’s potential in AD treatment. Hum Cell 34(6):1734–1743
Article PubMed CAS Google Scholar
Wei P, Pattarini R, Rong Y, Guo H, Bansal PK, Kusnoor SV, Deutch AY, Parris J, Morgan JI (2012) The Cbln family of proteins interact with multiple signaling pathways. J Neurochem 121(5):717–729
Article PubMed PubMed Central CAS Google Scholar
Xia L, Zhang F, Li Y, Mo Y, Zhang L, Li Q, Luo M, Hou X, Du Z, Deng J et al (2023) A new perspective on Alzheimer’s disease: m6A modification. Front Genet 14:1166831
Article PubMed PubMed Central CAS Google Scholar
Yang Y, Hsu PJ, Chen YS, Yang YG (2018) Dynamic transcriptomic m(6)a decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res 28(6):616–624
Article PubMed PubMed Central CAS Google Scholar
Zhang N, Ding C, Zuo Y, Peng Y, Zuo L (2022) N6-methyladenosine and neurological diseases. Mol Neurobiol 59(3):1925–1937
Article PubMed CAS Google Scholar
Zhao F, Xu Y, Gao S, Qin L, Austria Q, Siedlak SL, Pajdzik K, Dai Q, He C, Wang W et al (2021) METTL3-dependent RNA m(6)a dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events. Mol Neurodegeneration 16(1):70
Zhang TP, Li R, Wang LJ, Huang Q, Li HM (2022) Roles of the m6A methyltransferases METTL3, METTL14, and WTAP in pulmonary tuberculosis. Front Immunol 13:992628
Article PubMed PubMed Central CAS Google Scholar
Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT (2021) The epidemiology of Alzheimer’s Disease Modifiable Risk factors and Prevention. J Prev Alzheimer’s Disease 8(3):313–321
Comments (0)